Influenza Update for the 2020 - 2021 Flu Season
Infectious Diseases Society of AmericaPublished: March 3, 2021
- Key Points
- Testing and Treatment of Influenza When SARS-CoV-2 and Influenza Viruses are Co-circulating
- Prevention
- Chemoprophylaxis
- Treatment
- Antiviral Dosing
- Antiviral Treatment for Suspected or Confirmed Influenza
- Bacterial Coinfection
- Antiviral Failure
- Antiviral-resistant Infection Testing
- Adjunctive Therapy
- Institutional Outbreak Control
- Diagnosis
- Testing
- Outpatients (including emergency department patients)
- Hospitalized Patients
- Specimens
- Diagnostic Tests* Tables
- Influenza Vaccines — United States, 2020–21 Influenza Season
- Contraindications and Precautions to the Use of
- Testing
- Influenza Vaccines — United States, 2020–21 Influenza Season
- Dose Volumes for Inactivated Influenza Vaccines
- Licensed for Children Aged 6 through 35 months— United States, 2020–21 Influenza Season
- Antiviral Agents and Dosing Recommendations for
- Treatment and Chemoprophylaxis of Influenza
- Control Measures for Managing Institutional Influenza Outbreaks
- Signs and Symptoms of Uncomplicated Influenza
- Clinical Manifestations and Complications
- Associated With Influenza
- Persons Who Are at High Risk of Complications
- From Influenza
- Groups in Whom to Consider a Diagnosis of Influenza
- Influenza Diagnostic Tests for Respiratory Specimens
- Multiplex Assays Authorized for Simultaneous Detection of Influenza Viruses and SARS-CoV-2 by FDA Emergency Use Authorization - List of Differential Diagnoses to Consider for Patients With Influenza Who Do Not Improve or Have Clinical Deterioration With Antiviral Treatment
- Figures
- Influenza Vaccine Dosing Algorithm for Children Aged 6 months through 8 years — Advisory Committee on Immunization Practices, United States, 2020–21 Influenza Season
- Algorithm
- Guide for Considering Influenza Testing When Influenza Viruses are Circulating in the Community (regardless of influenza vaccination history)
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.